January 5, 2026 — Leads & Copy — Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) will participate in the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13th, 2026, at 3:00 p.m. PST / 6:00 p.m. EST.
A live webcast of the presentation will be available on the Investor Relations page of Zai Lab’s website at ir.zailaboratory.com/webcasts-presentations. An archived replay will be available for up to 30 days following the completion of the event.
Zai Lab Limited is an innovative, research-based, commercial-stage biopharmaceutical company based in China and the United States. The company is focused on discovering, developing, and commercializing innovative products that address medical conditions with significant unmet needs in the areas of oncology, immunology, neuroscience, and infectious disease. Zai Lab’s goal is to leverage its competencies and resources to positively impact human health.
For additional information about Zai Lab, please visit www.zailaboratory.com or follow at www.twitter.com/ZaiLab_Global.
Source: Zai Lab
